Denise Yates

8PUBLICATIONS
45CO-AUTHORS
Molecular targetsRespiratory diseasesHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 24, 2026
Cardiac Safety of Chronic Inhibition of the Myostatin-Activin Pathway with Bimagrumab in Healthy Older Adults.

Daniel Rooks, Denise P Yates, Srikanth Neelakantham

|Jun 21, 2024
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Preserved Ejection Fraction: The PARAGON-HF Proteomic Substudy.

Natasha L Patel-Murray, Luqing Zhang, Brian L Claggett

|May 03, 2024
Effect of Clonal Hematopoiesis Mutations and Canakinumab Treatment on Incidence of Solid Tumors in the CANTOS Randomized Clinical Trial.

Janghee Woo, Tingting Zhai, Fang Yang

|Nov 07, 2023
Effects of IL-1β inhibition on anemia and clonal hematopoiesis in the randomized CANTOS trial.

Janghee Woo, Darlene Lu, Andrew Lewandowski

|Aug 27, 2022
Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction.

Luqing Zhang, Jonathan W Cunningham, Brian L Claggett

|Oct 19, 2021
Coronary Artery Disease Polygenic Risk Score Identifies Patients at Higher Risk for Recurrent Cardiovascular Events in the CANTOS Trial.

Huilei Xu, Claudia Hon, Sergio Kaiser

Pageof 2

Frequent Collaborators

4 joint publications

Margaret L Healey

3 joint publications

Huilei Xu

3 joint publications

Michael T Beste

2 joint publications

Jason M Laramie